Syndesi’s work is being evaluated for the potential treatment of cognitive impairment and other symptoms associated with disorders such as Alzheimer’s disease and major depressive disorder.

US pharma giant Abbvie will pay up to $1 billion (€895 million) for an Irish-funded company that is chasing a treatment for dementia and other cogniti(...)

Neuromod founder and chief executive  Dr Ross O’Neill, with the company’s tinnitus therapy, Lenire. Photograph:  Julien Behal.

A tinnitus therapy developed by Irish company Neuromod has delivered results in a real-world study. The independent study by Hannover Medical School’(...)

Fountain Healthcare joins Gilde Healthcare, Inkef Capital, Johnson & Johnson Innovation and M Ventures as investors in Calypso, which develops novel biologics to address immunological diseases. Photograph: iStock

Irish life sciences venture capital group Fountain Healthcare Partners has invested in biotech Calypso Biotech as part of an €8 million extension to t(...)

Irish company Mainstay Medical  has developed a device to address chronic lower back pain

Irish company Mainstay Medical, which has developed a device to address chronic lower back pain, has raised $108 million(€89 million) to commercialis(...)

Oranmore-based Neurent   stand on the cusp of breaking into a multibillion dollar market  with their runny nose treatment. Photograph: iStock

Raising $25 million (€20.6 million) for a cure to runny noses is impressive. But the bigger news for Oranmore-based Neurent is that they stand on the (...)

Neurent Medical founders David Townley (left) and Brian Shields with their Neuromark system.

A Galway medtech company on the verge of securing US approval for a device to provide relief for people suffering from a chronic runny nose has raised(...)

Aidan King, Dr Manus Rogan and Dr Ena Prosser of Fountain Healthcare Partners.  Photograph: Nick Bradshaw

Irish life sciences investor Fountain Healthcare Partners has closed its third fund, having raised €125 million. It brings to just over €300 million t(...)

Photograph: iStock

A clinical trial of Irish medtech company Neuromod Devices’s treatment for tinnitus has shown a significant improvement in symptoms after 12 weeks. (...)

Inflazome chairman Dr Manus Rogan with co-founders Dr Matt Cooper and and Prof Luke O’Neill, and Dr Jeremy Skillington, vice-president of business development. Photograph: Nick Bradshaw

Covid-19 might be making 2020 an annus horribilis for most businesses, but it has been a year to remember for Fountain Healthcare Partners. The ventu(...)

Inflazome chairman Dr Manus Rogan, co-founders Dr Matt Cooper and Prof Luke O’Neill, and Dr Jeremy Skillington, vice-president, business development, photographed in 2016. Photograph: Nick Bradshaw

Swiss drug giant Roche has paid €380 million upfront for a four-year-old Irish biotech company working on treatments to meet clinically unmet needs in(...)

  • 1
  • 2
  • 3
  • 4
  • 5
  • Next
  • Last »